Liquidia (LQDA) Cash & Equivalents (2020 - 2026)

Liquidia's (LQDA) quarterly Cash & Equivalents came in at $222.8 million in Q1 2026, up 31.24% year-on-year from $169.8 million in Q1 2025, and up 16.84% quarter-over-quarter from $190.7 million in Q4 2025.

Liquidia (LQDA) Cash & Equivalents (2020 - 2026) Analysis & Trends

Liquidia's Cash & Equivalents history runs 7 years deep, the most recent figure standing at $222.8 million for Q1 2026.

  • On a quarterly basis, Cash & Equivalents rose 31.24% year-over-year to $222.8 million in Q1 2026; TTM through Mar 2026 was $222.8 million, a 31.24% increase from a year earlier, with the FY2025 full-year figure at $190.7 million, up 8.05% from the prior year.
  • Cash & Equivalents grew to $222.8 million in Q1 2026 per LQDA's latest filing, from $190.7 million in the prior quarter.
  • Across five years, Cash & Equivalents topped out at $222.8 million in Q1 2026 and bottomed at $57.8 million in Q1 2022.
  • The 5-year median for Cash & Equivalents is $133.1 million (2024), against an average of $134.2 million.
  • Across the five-year window, Cash & Equivalents surged 168.11% in 2024 and dropped 22.94% in 2025, its largest moves.
  • Year by year, Cash & Equivalents stood at $93.3 million in 2022, then dropped by 10.3% to $83.7 million in 2023, then soared by 110.9% to $176.5 million in 2024, then advanced by 8.05% to $190.7 million in 2025, then gained by 16.84% to $222.8 million in 2026.
  • Per Business Quant, the three latest LQDA Cash & Equivalents figures stand at $222.8 million (Q1 2026), $190.7 million (Q4 2025), and $157.5 million (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Equiv. (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - 1.76 Bn
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn 3.74 Bn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn 1.94 Bn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn 3.79 Bn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn 1.28 Bn
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - 33.59 Bn
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn 1.80 Bn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn 266.50 Mn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn 428.00 Mn
10 Liquidia 7.84 Bn 7.61 Bn 121.79 Mn 222.79 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 222.79 Mn
Dec 31, 2025 190.68 Mn
Sep 30, 2025 157.50 Mn
Jun 30, 2025 173.42 Mn
Mar 31, 2025 169.76 Mn
Dec 31, 2024 176.48 Mn
Sep 30, 2024 204.37 Mn
Jun 30, 2024 133.09 Mn
Mar 31, 2024 157.86 Mn
Dec 31, 2023 83.68 Mn
Sep 30, 2023 76.23 Mn
Jun 30, 2023 88.20 Mn
Mar 31, 2023 94.41 Mn
Dec 31, 2022 93.28 Mn
Sep 30, 2022 98.32 Mn
Jun 30, 2022 103.84 Mn
Mar 31, 2022 57.80 Mn
Dec 31, 2021 57.49 Mn
Sep 30, 2021 64.10 Mn
Jun 30, 2021 67.89 Mn